Literature DB >> 15613948

Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples.

Enrique F Schisterman1, Neil J Perkins, Aiyi Liu, Howard Bondell.   

Abstract

Costs can hamper the evaluation of the effectiveness of new biomarkers. Analysis of smaller numbers of pooled specimens has been shown to be a useful cost-cutting technique. The Youden index (J), a function of sensitivity (q) and specificity (p), is a commonly used measure of overall diagnostic effectiveness. More importantly, J is the maximum vertical distance or difference between the ROC curve and the diagonal or chance line; it occurs at the cut-point that optimizes the biomarker's differentiating ability when equal weight is given to sensitivity and specificity. Using the additive property of the gamma and normal distributions, we present a method to estimate the Youden index and the optimal cut-point, and extend its applications to pooled samples. We study the effect of pooling when only a fixed number of individuals are available for testing, and pooling is carried out to save on the number of assays. We measure loss of information by the change in root mean squared error of the estimates of the optimal cut-point and the Youden index, and we study the extent of this loss via a simulation study. In conclusion, pooling can result in a substantial cost reduction while preserving the effectiveness of estimators, especially when the pool size is not very large.

Mesh:

Substances:

Year:  2005        PMID: 15613948     DOI: 10.1097/01.ede.0000147512.81966.ba

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  322 in total

1.  The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.

Authors:  Grant Theron; Lancelot Pinto; Jonny Peter; Hemant Kumar Mishra; Hridesh Kumar Mishra; Richard van Zyl-Smit; Surendra Kumar Sharma; Keertan Dheda
Journal:  Clin Infect Dis       Date:  2011-12-01       Impact factor: 9.079

Review 2.  A Review of Cutoffs for Nutritional Biomarkers.

Authors:  Ramkripa Raghavan; Fayrouz Sakr Ashour; Regan Bailey
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

3.  Case-control data analysis for randomly pooled biomarkers.

Authors:  Neil J Perkins; Emily M Mitchell; Robert H Lyles; Enrique F Schisterman
Journal:  Biom J       Date:  2016-01-29       Impact factor: 2.207

4.  The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve.

Authors:  Neil J Perkins; Enrique F Schisterman
Journal:  Am J Epidemiol       Date:  2006-01-12       Impact factor: 4.897

5.  Youden Index and the optimal threshold for markers with mass at zero.

Authors:  Enrique F Schisterman; David Faraggi; Benjamin Reiser; Jessica Hu
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

6.  Pooling data when analyzing biomarkers subject to a limit of detection.

Authors:  Leslie Rosenthal; Enrique Schisterman
Journal:  Methods Mol Biol       Date:  2008

7.  Demonstration of a software design and statistical analysis methodology with application to patient outcomes data sets.

Authors:  Charles Mayo; Steve Conners; Christopher Warren; Robert Miller; Laurence Court; Richard Popple
Journal:  Med Phys       Date:  2013-11       Impact factor: 4.071

8.  The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Authors:  Jing Yu; Qing Xu; Jia-Cheng Song; Yan Li; Xin Dai; Dong-Ya Huang; Ling Zhang; Yang Li; Hai-Bin Shi
Journal:  Eur Radiol       Date:  2016-09-08       Impact factor: 5.315

9.  Evaluation of an IgG Enzyme-Linked Immunosorbent Assay as a Serological Assay for Detection of Mycoplasma bovis Infection in Feedlot Cattle.

Authors:  Nadeeka K Wawegama; Philip F Markham; Anna Kanci; Meghan Schibrowski; Sally Oswin; Tamsin S Barnes; Simon M Firestone; Timothy J Mahony; Glenn F Browning
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

10.  The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy?

Authors:  Guo-Wen Lin; Xu-Dong Yao; Ding-Wei Ye; Yao Zhu; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen; Chun-Guang Ma
Journal:  Asian J Androl       Date:  2012-08-20       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.